BACKGROUND. Overexpression of cyclin D1 has been documented in a number of
human cancers. Increased expression of cyclin D1 can contribute to cellular
transformation and abnormal proliferation.
METHODS. Quantitative RT-PCR and/or Western blot analysis were used to dete
rmine the level of cyclin D1 expression in 96 human prostate tumors, 15 ben
ign prostate hyperplasias, 4 prostate cancer cell lines, and 3 xenografts.
RESULTS. Our results demonstrate that 4.2% of the prostate tumors examined
overexpressed cyclin D1 trasnscripts. In the cell lines, expression was nor
mal, with the exception that reduced levels of cyclin D1 transcript and pro
tein were observed in the DU145 cell Line, as expected from cells with muta
nt RB. Normal levels of cyclin D1 were found in all xenograft tumors and BP
H specimens examined.
CONCLUSIONS. These data show that overexpression of cyclin D1 occurs rarely
in human prostate tumors. However, when overexpression of cyclin D1 does o
ccur, it may identify a subset of tumors with a different molecular biology
. (C) 1999 Wiley-Liss, Inc.